Mangoceuticals, Inc. Retained Earnings
Mangoceuticals, Inc. (MGRX) had Retained Earnings of -$45.36 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-13
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$45.36M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$44.05M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$40.65M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$37.88M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$45.36M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | -$44.05M 10-Q · filed 2026-05-19 | |
| 2025-12-31 | -$40.65M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | -$37.88M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | -$31.65M 10-Q/A · filed 2025-11-14 | |
| 2025-03-31 | -$25.94M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | -$20.00M 10-K · filed 2026-04-01 | -$20.81M 10-K · filed 2025-03-20 |
| 2024-09-30 | -$17.99M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | -$15.99M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | -$13.60M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | -$11.23M 10-K · filed 2025-03-20 | |
| 2023-09-30 | -$8.66M 10-Q · filed 2023-10-27 | |
| 2023-06-30 | -$6.86M 10-Q · filed 2023-07-28 | |
| 2023-03-31 | -$4.58M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | -$2.02M 10-K · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |